Published: 7 December 2023
Publications
Quarterly summary of recent safety communications
Published: 7 December 2023
Prescriber Update 44(4): 76
December 2023
The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.
| Date | Communication | Topic |
|---|---|---|
| 20/11/2023 | Monitoring | 
Update – Interleukin inhibitors and the possible risk of pancreatitis |
| 26/10/2023 | Committees | Reclassification of methenamine hippurate |
| 17/10/2023 | Committees | Reclassification of low-dose cannabidiol |
| 26/9/2023 | Committees | Reclassification of naproxen |
| 26/9/2023 | Committees | Reclassification of paracetamol (liquid formulations) |
| 25/09/2023 | Alert | Consent to distribute pholcodine-containing medicines will be revoked on 12 January 2024 |
| 4/09/2023 | Alert | Processing of adverse reaction reports received in New Zealand (PDF, 2 pages, 189 KB) |
